{"id":{"repo_id":"ajou","oai_identifier":"oai:repository.ajou.ac.kr:201003/1263"},"canonical_url":"https://search.dev.ndltd.org/etd/ajou/oai:repository.ajou.ac.kr:201003/1263","repository":{"repo_id":"ajou","name":"Ajou University","base_url":"http://repository.ajou.ac.kr/oai/request"},"display":{"title":"비인강암 환자에서 Excision Repair Cross-Complementation Group1 단백의 과발현이 예후에 미치는 영향","abstract":"\"ABSTRACT ⅰ TABLE OF CONTENTS iii LIST OF FIGURES v LIST OF TABLES vi Ⅰ. INTRODUCTION 1 Ⅱ. PATIENTS AND METHODS 3 A. PATIENTS 3 B. METHODS 3 1. Chemoradiotherapy 3 2. Evaluation 4 3. Immunohistochemical staining for ERCC1, TS and Bax 4 4. Statistical analysis 5 Ⅲ. RESULTS 7 1. Patients characteristics 7 2. Treatment response 8 3. Association of expression of drug resistance-related proteins with clinicopathologic charecteristics 9 4. Association between expression of drug resistance-related proteins with patients outcomes 12 Ⅳ. DISCUSSION 16 Ⅴ. CONCLUSION 19 REFERENCES 20 국문요약 26\"","abstract_html":""ABSTRACT ⅰ TABLE OF CONTENTS iii LIST OF FIGURES v LIST OF TABLES vi Ⅰ. INTRODUCTION 1 Ⅱ. PATIENTS AND METHODS 3 A. PATIENTS 3 B. METHODS 3 1. Chemoradiotherapy 3 2. Evaluation 4 3. Immunohistochemical staining for ERCC1, TS and Bax 4 4. Statistical analysis 5 Ⅲ. RESULTS 7 1. Patients characteristics 7 2. Treatment response 8 3. Association of expression of drug resistance-related proteins with clinicopathologic charecteristics 9 4. Association between expression of drug resistance-related proteins with patients outcomes 12 Ⅳ. DISCUSSION 16 Ⅴ. CONCLUSION 19 REFERENCES 20 국문요약 26"","abstract_has_math":false,"creators":["황, 윤호"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["최, 진혁","대학원 의학과","200724504"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-01-26","date_published":"2011-01-26","updated_at":"2026-07-24T00:51:19Z","subjects":[],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000010688","000000010688"],"render_values":[{"text":"http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000010688","href":"http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000010688","code":true},{"text":"000000010688","href":null,"code":true}]}]},"links":{"outbound_url":"http://repository.ajou.ac.kr/handle/201003/1263","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["최, 진혁","대학원 의학과","200724504","황, 윤호"]},{"key":"dc:creator","label":"Author","values":["황, 윤호"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2011-01-26","2010"]},{"key":"dc:type","label":"Dc Type","values":["Thesis","Theses"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://repository.ajou.ac.kr/handle/201003/1263","http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000010688","000000010688"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["\"ABSTRACT ⅰ TABLE OF CONTENTS iii LIST OF FIGURES v LIST OF TABLES vi Ⅰ. INTRODUCTION 1 Ⅱ. PATIENTS AND METHODS 3 A. PATIENTS 3 B. METHODS 3 1. Chemoradiotherapy 3 2. Evaluation 4 3. Immunohistochemical staining for ERCC1, TS and Bax 4 4. Statistical analysis 5 Ⅲ. RESULTS 7 1. Patients characteristics 7 2. Treatment response 8 3. Association of expression of drug resistance-related proteins with clinicopathologic charecteristics 9 4. Association between expression of drug resistance-related proteins with patients outcomes 12 Ⅳ. DISCUSSION 16 Ⅴ. CONCLUSION 19 REFERENCES 20 국문요약 26\"","Master"]},{"key":"dc:title","label":"Title","values":["비인강암 환자에서 Excision Repair Cross-Complementation Group1 단백의 과발현이 예후에 미치는 영향"]}]}],"canonical_facts":{"dc:contributor":["최, 진혁","대학원 의학과","200724504","황, 윤호"],"dc:creator":["황, 윤호"],"dc:date":["2011-01-26","2010"],"dc:description":["\"ABSTRACT ⅰ TABLE OF CONTENTS iii LIST OF FIGURES v LIST OF TABLES vi Ⅰ. INTRODUCTION 1 Ⅱ. PATIENTS AND METHODS 3 A. PATIENTS 3 B. METHODS 3 1. Chemoradiotherapy 3 2. Evaluation 4 3. Immunohistochemical staining for ERCC1, TS and Bax 4 4. Statistical analysis 5 Ⅲ. RESULTS 7 1. Patients characteristics 7 2. Treatment response 8 3. Association of expression of drug resistance-related proteins with clinicopathologic charecteristics 9 4. Association between expression of drug resistance-related proteins with patients outcomes 12 Ⅳ. DISCUSSION 16 Ⅴ. CONCLUSION 19 REFERENCES 20 국문요약 26\"","Master"],"dc:identifier":["http://repository.ajou.ac.kr/handle/201003/1263","http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000010688","000000010688"],"dc:language":["en"],"dc:title":["비인강암 환자에서 Excision Repair Cross-Complementation Group1 단백의 과발현이 예후에 미치는 영향"],"dc:type":["Thesis","Theses"]},"updated_at":"2026-07-24T00:51:19Z"}